John Carlo Salvaleon
About John Carlo Salvaleon
John Carlo Salvaleon is a Cell Therapy Specialist I at Kite Pharma, where he focuses on optimizing processes and ensuring compliance with cGMP regulations. He has previous experience in various roles within the pharmaceutical and food service industries, including positions at West Pharmaceutical Services and Mylan.
Work at Kite Pharma
John Carlo Salvaleon has been employed at Kite Pharma as a Cell Therapy Specialist I since 2020. In this role, he is responsible for ensuring compliance with current Good Manufacturing Practices (cGMP) regulations and maintaining high-quality output in both clinical and commercial manufacturing processes. He collaborates closely with various teams, including Product Sciences, Material Management, and Quality Assurance & Quality Control, to execute GMP runs. Salvaleon actively seeks process improvements to enhance quality and efficiency within the manufacturing environment.
Previous Experience in Pharmaceutical Operations
Prior to his role at Kite Pharma, Salvaleon worked at West Pharmaceutical Services as a Production Operator from 2018 to 2019 in Dublin, Ireland. He also held a position at Mylan as a Process Operator for four months in 2019 and again for another four months in 2020, both in Dublin. His experience includes optimizing standard operating procedures and batch records to support process improvements, as well as managing change controls and conducting investigations to address deviations in the manufacturing process.
Culinary Experience
Before entering the pharmaceutical industry, Salvaleon gained culinary experience working at wagamama. He served as a Line Chef from 2017 to 2018 for seven months in Dublin, and later as an Assistant Prep Chef from 2019 to 2020 for seven months in Blanchardstown, Dublin. This background provided him with valuable skills in a fast-paced environment, contributing to his overall work ethic and attention to detail.
Education and Qualifications
Salvaleon studied at Technological University Dublin, where he completed a BSc in Science with Nanotechnology, achieving a Second Class Honours - Lower Division (2.2) from 2011 to 2016. He furthered his education by obtaining a CPD Masters Qualifier in Fundamentals of Computing from 2019 to 2020. His academic background supports his technical expertise in the pharmaceutical and manufacturing sectors.